» Articles » PMID: 37996688

Mechanisms of Cell Fusion in Cancer

Overview
Specialty Cell Biology
Date 2023 Nov 23
PMID 37996688
Authors
Affiliations
Soon will be listed here.
Abstract

Cell-cell fusion is a normal physiological mechanism that requires a well-orchestrated regulation of intracellular and extracellular factors. Dysregulation of this process could lead to diseases such as osteoporosis, malformation of muscles, difficulties in pregnancy, and cancer. Extensive literature demonstrates that fusion occurs between cancer cells and other cell types to potentially promote cancer progression and metastasis. However, the mechanisms governing this process in cancer initiation, promotion, and progression are less well-studied. Fusogens involved in normal physiological processes such as syncytins and associated factors such as phosphatidylserine and annexins have been observed to be critical in cancer cell fusion as well. Some of the extracellular factors associated with cancer cell fusion include chronic inflammation and inflammatory cytokines, hypoxia, and viral infection. The interaction between these extracellular factors and cell's intrinsic factors potentially modulates actin dynamics to drive the fusion of cancer cells. In this review, we have discussed the different mechanisms that have been identified or postulated to drive cancer cell fusion.

References
1.
Chakraborty A, Lazova R, Davies S, Backvall H, Ponten F, Brash D . Donor DNA in a renal cell carcinoma metastasis from a bone marrow transplant recipient. Bone Marrow Transplant. 2004; 34(2):183-6. DOI: 10.1038/sj.bmt.1704547. View

2.
Park S, Yun Y, Lim J, Kim M, Kim S, Kim J . Stabilin-2 modulates the efficiency of myoblast fusion during myogenic differentiation and muscle regeneration. Nat Commun. 2016; 7:10871. PMC: 4793076. DOI: 10.1038/ncomms10871. View

3.
Song K, Zhu F, Zhang H, Shang Z . Tumor necrosis factor-α enhanced fusions between oral squamous cell carcinoma cells and endothelial cells via VCAM-1/VLA-4 pathway. Exp Cell Res. 2012; 318(14):1707-15. DOI: 10.1016/j.yexcr.2012.05.022. View

4.
Lemaitre C, Tsang J, Bireau C, Heidmann T, Dewannieux M . A human endogenous retrovirus-derived gene that can contribute to oncogenesis by activating the ERK pathway and inducing migration and invasion. PLoS Pathog. 2017; 13(6):e1006451. PMC: 5501692. DOI: 10.1371/journal.ppat.1006451. View

5.
Zhou X, Platt J . Molecular and cellular mechanisms of mammalian cell fusion. Adv Exp Med Biol. 2011; 713:33-64. DOI: 10.1007/978-94-007-0763-4_4. View